Reported Earlier, Monopar Therapeutics Prices $19.2M Public Offering Of Common Shares At $16.25/Share
Portfolio Pulse from Benzinga Newsdesk
Monopar Therapeutics has announced a public offering of common shares, raising $19.2 million at a price of $16.25 per share.
October 29, 2024 | 7:38 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Monopar Therapeutics has priced a public offering of common shares, raising $19.2 million at $16.25 per share. This move could impact the stock price due to dilution and increased capital.
The public offering increases the number of shares outstanding, which can lead to dilution of existing shares. However, the raised capital could be used for growth, offsetting some negative impacts. The immediate effect is likely a short-term decrease in stock price due to dilution concerns.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100